Fred Jacobs

Fred Jacobs is the Chief Executive Officer (CEO) and Co-Founder of TYG Oncology, a biotech company that develops novel cancer immunotherapies.12 Here are some key details about Fred Jacobs:

Professional Background

Fred Jacobs has extensive experience in the healthcare and biotechnology sectors. He started his healthcare career with a US Health Maintenance Organization before moving into the biotech industry.5 His expertise lies in business development, marketing, and relationship management in the investment servicing and technology spaces.6

Role at TYG Oncology

As CEO and Co-Founder of TYG Oncology, Fred Jacobs leads a company that focuses on developing innovative cancer treatments. TYG Oncology's primary technology is the S-TIR™ (Specific Total Immune Remodulation) platform, which aims to boost patients' immune systems to generate strong, specific, and controlled immune responses against cancer.2

Contact Information

Fred Jacobs can be reached via:

• Email: fred.jacobs@tyg-oncology.com
• Phone: +44 798 93863261

Location and Network

Fred Jacobs is based in Nottinghamshire, England, United Kingdom. His LinkedIn profile shows that he has over 500 connections in his professional network.4

Industry Involvement

Fred Jacobs is active in the biotechnology and oncology sectors. He has participated in industry events such as the Oncology Strategy Meeting in London, where he served as a facilitator.3 This involvement demonstrates his engagement with the broader oncology community and his role in shaping industry strategies.